nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—TUBA4A—Vincristine—sarcoma	0.141	0.176	CbGbCtD
Cabazitaxel—TUBB2B—Vincristine—sarcoma	0.0644	0.0801	CbGbCtD
Cabazitaxel—TUBB4A—Vincristine—sarcoma	0.0644	0.0801	CbGbCtD
Cabazitaxel—TUBB3—Vincristine—sarcoma	0.0644	0.0801	CbGbCtD
Cabazitaxel—TUBB2A—Vincristine—sarcoma	0.0644	0.0801	CbGbCtD
Cabazitaxel—TUBB6—Vincristine—sarcoma	0.0644	0.0801	CbGbCtD
Cabazitaxel—TUBB8—Vincristine—sarcoma	0.0644	0.0801	CbGbCtD
Cabazitaxel—TUBB4B—Vincristine—sarcoma	0.0539	0.067	CbGbCtD
Cabazitaxel—TUBB1—Vincristine—sarcoma	0.0539	0.067	CbGbCtD
Cabazitaxel—TUBB—Vincristine—sarcoma	0.0539	0.067	CbGbCtD
Cabazitaxel—ABCG2—Dactinomycin—sarcoma	0.0173	0.0215	CbGbCtD
Cabazitaxel—ABCG2—Mitoxantrone—sarcoma	0.0155	0.0192	CbGbCtD
Cabazitaxel—ABCG2—Vincristine—sarcoma	0.0106	0.0132	CbGbCtD
Cabazitaxel—ABCG2—Etoposide—sarcoma	0.00975	0.0121	CbGbCtD
Cabazitaxel—CYP3A4—Thiotepa—sarcoma	0.00777	0.00966	CbGbCtD
Cabazitaxel—ABCG2—Doxorubicin—sarcoma	0.00665	0.00827	CbGbCtD
Cabazitaxel—ABCB1—Dactinomycin—sarcoma	0.00623	0.00774	CbGbCtD
Cabazitaxel—CYP3A5—Vincristine—sarcoma	0.00589	0.00733	CbGbCtD
Cabazitaxel—ABCB1—Mitoxantrone—sarcoma	0.00557	0.00693	CbGbCtD
Cabazitaxel—CYP3A5—Etoposide—sarcoma	0.0054	0.00672	CbGbCtD
Cabazitaxel—CYP2C8—Etoposide—sarcoma	0.00519	0.00646	CbGbCtD
Cabazitaxel—ABCB1—Vincristine—sarcoma	0.00384	0.00477	CbGbCtD
Cabazitaxel—ABCB1—Etoposide—sarcoma	0.00352	0.00437	CbGbCtD
Cabazitaxel—CYP3A4—Mitoxantrone—sarcoma	0.00334	0.00415	CbGbCtD
Cabazitaxel—ABCB1—Doxorubicin—sarcoma	0.0024	0.00298	CbGbCtD
Cabazitaxel—CYP3A4—Vincristine—sarcoma	0.0023	0.00286	CbGbCtD
Cabazitaxel—Docetaxel—EGFR—sarcoma	0.00221	1	CrCbGaD
Cabazitaxel—CYP3A4—Etoposide—sarcoma	0.00211	0.00262	CbGbCtD
Cabazitaxel—CYP3A4—Doxorubicin—sarcoma	0.00144	0.00179	CbGbCtD
Cabazitaxel—TUBA4A—mammary gland—sarcoma	0.00143	0.0238	CbGeAlD
Cabazitaxel—TUBB3—hematopoietic system—sarcoma	0.00115	0.0191	CbGeAlD
Cabazitaxel—TUBB1—hematopoietic system—sarcoma	0.00113	0.0186	CbGeAlD
Cabazitaxel—TUBB3—connective tissue—sarcoma	0.00111	0.0184	CbGeAlD
Cabazitaxel—TUBB6—mammary gland—sarcoma	0.00103	0.0171	CbGeAlD
Cabazitaxel—TUBA4A—myometrium—sarcoma	0.00102	0.0169	CbGeAlD
Cabazitaxel—SLCO1B1—mammary gland—sarcoma	0.000957	0.0158	CbGeAlD
Cabazitaxel—TUBB8—testis—sarcoma	0.000924	0.0153	CbGeAlD
Cabazitaxel—TUBA4A—seminal vesicle—sarcoma	0.00092	0.0152	CbGeAlD
Cabazitaxel—TUBB4B—mammary gland—sarcoma	0.000897	0.0149	CbGeAlD
Cabazitaxel—TUBA4A—hematopoietic system—sarcoma	0.000874	0.0145	CbGeAlD
Cabazitaxel—TUBA4A—connective tissue—sarcoma	0.000842	0.0139	CbGeAlD
Cabazitaxel—TUBB3—lymphoid tissue—sarcoma	0.00081	0.0134	CbGeAlD
Cabazitaxel—TUBB2B—myometrium—sarcoma	0.000788	0.0131	CbGeAlD
Cabazitaxel—TUBB4A—embryo—sarcoma	0.000785	0.013	CbGeAlD
Cabazitaxel—TUBA4A—smooth muscle tissue—sarcoma	0.00077	0.0128	CbGeAlD
Cabazitaxel—TUBA4A—skin of body—sarcoma	0.00076	0.0126	CbGeAlD
Cabazitaxel—TUBB—myometrium—sarcoma	0.000746	0.0124	CbGeAlD
Cabazitaxel—TUBB2A—myometrium—sarcoma	0.000742	0.0123	CbGeAlD
Cabazitaxel—TUBB6—myometrium—sarcoma	0.000732	0.0121	CbGeAlD
Cabazitaxel—TUBB1—bone marrow—sarcoma	0.000722	0.012	CbGeAlD
Cabazitaxel—TUBB2B—seminal vesicle—sarcoma	0.000712	0.0118	CbGeAlD
Cabazitaxel—TUBB4A—hematopoietic system—sarcoma	0.0007	0.0116	CbGeAlD
Cabazitaxel—TUBB8—Pathogenic Escherichia coli infection—EZR—sarcoma	0.00069	0.079	CbGpPWpGaD
Cabazitaxel—TUBB4A—connective tissue—sarcoma	0.000674	0.0112	CbGeAlD
Cabazitaxel—TUBB—seminal vesicle—sarcoma	0.000674	0.0112	CbGeAlD
Cabazitaxel—TUBB2A—seminal vesicle—sarcoma	0.00067	0.0111	CbGeAlD
Cabazitaxel—TUBA4A—cardiac atrium—sarcoma	0.000664	0.011	CbGeAlD
Cabazitaxel—TUBB6—seminal vesicle—sarcoma	0.000661	0.011	CbGeAlD
Cabazitaxel—TUBA4A—uterus—sarcoma	0.00066	0.0109	CbGeAlD
Cabazitaxel—TUBB2B—connective tissue—sarcoma	0.000652	0.0108	CbGeAlD
Cabazitaxel—TUBB2A—hematopoietic system—sarcoma	0.000637	0.0106	CbGeAlD
Cabazitaxel—TUBB4B—myometrium—sarcoma	0.000636	0.0105	CbGeAlD
Cabazitaxel—TUBB3—testis—sarcoma	0.000631	0.0104	CbGeAlD
Cabazitaxel—TUBB6—hematopoietic system—sarcoma	0.000629	0.0104	CbGeAlD
Cabazitaxel—TUBB1—testis—sarcoma	0.000617	0.0102	CbGeAlD
Cabazitaxel—TUBA4A—lymphoid tissue—sarcoma	0.000615	0.0102	CbGeAlD
Cabazitaxel—TUBB2A—connective tissue—sarcoma	0.000614	0.0102	CbGeAlD
Cabazitaxel—TUBB4B—embryo—sarcoma	0.000612	0.0101	CbGeAlD
Cabazitaxel—TUBB4A—skin of body—sarcoma	0.000609	0.0101	CbGeAlD
Cabazitaxel—SLCO1B1—hematopoietic system—sarcoma	0.000583	0.00965	CbGeAlD
Cabazitaxel—TUBA4A—tendon—sarcoma	0.000578	0.00958	CbGeAlD
Cabazitaxel—TUBB4B—seminal vesicle—sarcoma	0.000575	0.00952	CbGeAlD
Cabazitaxel—TUBB—smooth muscle tissue—sarcoma	0.000564	0.00935	CbGeAlD
Cabazitaxel—TUBB2A—smooth muscle tissue—sarcoma	0.000561	0.0093	CbGeAlD
Cabazitaxel—TUBA4A—bone marrow—sarcoma	0.00056	0.00928	CbGeAlD
Cabazitaxel—TUBB2A—skin of body—sarcoma	0.000554	0.00918	CbGeAlD
Cabazitaxel—TUBB6—smooth muscle tissue—sarcoma	0.000554	0.00917	CbGeAlD
Cabazitaxel—TUBB6—skin of body—sarcoma	0.000546	0.00905	CbGeAlD
Cabazitaxel—TUBB4B—hematopoietic system—sarcoma	0.000546	0.00905	CbGeAlD
Cabazitaxel—CYP2C8—mammary gland—sarcoma	0.000544	0.00901	CbGeAlD
Cabazitaxel—TUBB4A—uterus—sarcoma	0.000529	0.00876	CbGeAlD
Cabazitaxel—TUBB4B—connective tissue—sarcoma	0.000526	0.00871	CbGeAlD
Cabazitaxel—SLCO1B3—liver—sarcoma	0.000522	0.00865	CbGeAlD
Cabazitaxel—TUBB2B—cardiac atrium—sarcoma	0.000514	0.00852	CbGeAlD
Cabazitaxel—TUBB4A—lymphoid tissue—sarcoma	0.000493	0.00817	CbGeAlD
Cabazitaxel—TUBB—cardiac atrium—sarcoma	0.000486	0.00806	CbGeAlD
Cabazitaxel—TUBB—uterus—sarcoma	0.000484	0.00802	CbGeAlD
Cabazitaxel—TUBB2A—cardiac atrium—sarcoma	0.000484	0.00802	CbGeAlD
Cabazitaxel—TUBB2A—uterus—sarcoma	0.000481	0.00797	CbGeAlD
Cabazitaxel—TUBB4B—smooth muscle tissue—sarcoma	0.000481	0.00797	CbGeAlD
Cabazitaxel—TUBA4A—testis—sarcoma	0.000479	0.00793	CbGeAlD
Cabazitaxel—TUBB6—cardiac atrium—sarcoma	0.000477	0.00791	CbGeAlD
Cabazitaxel—TUBB4B—skin of body—sarcoma	0.000475	0.00787	CbGeAlD
Cabazitaxel—TUBB6—uterus—sarcoma	0.000475	0.00786	CbGeAlD
Cabazitaxel—TUBB4A—tendon—sarcoma	0.000464	0.00768	CbGeAlD
Cabazitaxel—TUBA4A—liver—sarcoma	0.000453	0.0075	CbGeAlD
Cabazitaxel—TUBB2B—tendon—sarcoma	0.000448	0.00742	CbGeAlD
Cabazitaxel—TUBB6—lymphoid tissue—sarcoma	0.000442	0.00733	CbGeAlD
Cabazitaxel—TUBB—tendon—sarcoma	0.000424	0.00702	CbGeAlD
Cabazitaxel—TUBB2A—tendon—sarcoma	0.000422	0.00699	CbGeAlD
Cabazitaxel—TUBB6—tendon—sarcoma	0.000416	0.00689	CbGeAlD
Cabazitaxel—TUBB4B—cardiac atrium—sarcoma	0.000415	0.00687	CbGeAlD
Cabazitaxel—TUBB4B—uterus—sarcoma	0.000413	0.00684	CbGeAlD
Cabazitaxel—TUBB—bone marrow—sarcoma	0.000411	0.0068	CbGeAlD
Cabazitaxel—TUBB2A—bone marrow—sarcoma	0.000409	0.00677	CbGeAlD
Cabazitaxel—TUBA4A—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000407	0.0466	CbGpPWpGaD
Cabazitaxel—TUBB6—bone marrow—sarcoma	0.000403	0.00667	CbGeAlD
Cabazitaxel—TUBB4B—lymphoid tissue—sarcoma	0.000385	0.00637	CbGeAlD
Cabazitaxel—TUBB4A—testis—sarcoma	0.000384	0.00636	CbGeAlD
Cabazitaxel—ABCG2—myometrium—sarcoma	0.000375	0.00622	CbGeAlD
Cabazitaxel—TUBB2B—testis—sarcoma	0.000371	0.00615	CbGeAlD
Cabazitaxel—TUBB4A—liver—sarcoma	0.000363	0.00601	CbGeAlD
Cabazitaxel—TUBB4B—tendon—sarcoma	0.000362	0.00599	CbGeAlD
Cabazitaxel—TUBB—testis—sarcoma	0.000351	0.00582	CbGeAlD
Cabazitaxel—TUBB4B—bone marrow—sarcoma	0.00035	0.0058	CbGeAlD
Cabazitaxel—TUBB2A—Signaling events mediated by HDAC Class III—MYOD1—sarcoma	0.00035	0.0401	CbGpPWpGaD
Cabazitaxel—TUBB2A—testis—sarcoma	0.000349	0.00578	CbGeAlD
Cabazitaxel—TUBB2B—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000349	0.04	CbGpPWpGaD
Cabazitaxel—TUBB6—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000349	0.04	CbGpPWpGaD
Cabazitaxel—TUBA4A—lymph node—sarcoma	0.000347	0.00575	CbGeAlD
Cabazitaxel—TUBB—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000346	0.0396	CbGpPWpGaD
Cabazitaxel—TUBB6—testis—sarcoma	0.000344	0.00571	CbGeAlD
Cabazitaxel—ABCG2—seminal vesicle—sarcoma	0.000339	0.00562	CbGeAlD
Cabazitaxel—TUBB3—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000337	0.0386	CbGpPWpGaD
Cabazitaxel—TUBB—liver—sarcoma	0.000332	0.0055	CbGeAlD
Cabazitaxel—CYP2C8—hematopoietic system—sarcoma	0.000331	0.00549	CbGeAlD
Cabazitaxel—TUBB2A—liver—sarcoma	0.00033	0.00547	CbGeAlD
Cabazitaxel—TUBB2A—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000326	0.0374	CbGpPWpGaD
Cabazitaxel—TUBB6—liver—sarcoma	0.000326	0.00539	CbGeAlD
Cabazitaxel—TUBB1—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000319	0.0366	CbGpPWpGaD
Cabazitaxel—SLCO1B1—liver—sarcoma	0.000302	0.005	CbGeAlD
Cabazitaxel—TUBB4B—testis—sarcoma	0.000299	0.00496	CbGeAlD
Cabazitaxel—CYP3A5—hematopoietic system—sarcoma	0.000299	0.00495	CbGeAlD
Cabazitaxel—TUBB4A—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000286	0.0328	CbGpPWpGaD
Cabazitaxel—TUBB4B—liver—sarcoma	0.000283	0.00469	CbGeAlD
Cabazitaxel—TUBB4A—lymph node—sarcoma	0.000278	0.00461	CbGeAlD
Cabazitaxel—TUBB2B—lymph node—sarcoma	0.000269	0.00445	CbGeAlD
Cabazitaxel—TUBB4B—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000262	0.03	CbGpPWpGaD
Cabazitaxel—TUBB—lymph node—sarcoma	0.000254	0.00422	CbGeAlD
Cabazitaxel—TUBB2A—lymph node—sarcoma	0.000253	0.00419	CbGeAlD
Cabazitaxel—TUBB6—lymph node—sarcoma	0.00025	0.00414	CbGeAlD
Cabazitaxel—ABCG2—uterus—sarcoma	0.000243	0.00403	CbGeAlD
Cabazitaxel—CYP3A4—hematopoietic system—sarcoma	0.000224	0.00372	CbGeAlD
Cabazitaxel—TUBA4A—Platelet degranulation—VEGFC—sarcoma	0.000221	0.0253	CbGpPWpGaD
Cabazitaxel—TUBB4B—lymph node—sarcoma	0.000217	0.00359	CbGeAlD
Cabazitaxel—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFC—sarcoma	0.000211	0.0241	CbGpPWpGaD
Cabazitaxel—ABCG2—bone marrow—sarcoma	0.000207	0.00342	CbGeAlD
Cabazitaxel—ABCB1—myometrium—sarcoma	0.000185	0.00307	CbGeAlD
Cabazitaxel—CYP2C8—testis—sarcoma	0.000182	0.00301	CbGeAlD
Cabazitaxel—ABCB1—embryo—sarcoma	0.000178	0.00295	CbGeAlD
Cabazitaxel—ABCG2—testis—sarcoma	0.000177	0.00293	CbGeAlD
Cabazitaxel—TUBB2A—Signaling events mediated by HDAC Class III—FOXO1—sarcoma	0.000176	0.0201	CbGpPWpGaD
Cabazitaxel—CYP2C8—liver—sarcoma	0.000172	0.00284	CbGeAlD
Cabazitaxel—ABCB1—seminal vesicle—sarcoma	0.000167	0.00277	CbGeAlD
Cabazitaxel—ABCG2—liver—sarcoma	0.000167	0.00277	CbGeAlD
Cabazitaxel—ABCB1—hematopoietic system—sarcoma	0.000159	0.00263	CbGeAlD
Cabazitaxel—Fatigue—Vincristine—sarcoma	0.000156	0.00125	CcSEcCtD
Cabazitaxel—Dehydration—Epirubicin—sarcoma	0.000155	0.00125	CcSEcCtD
Cabazitaxel—CYP3A5—liver—sarcoma	0.000155	0.00257	CbGeAlD
Cabazitaxel—Dyspepsia—Mitoxantrone—sarcoma	0.000155	0.00125	CcSEcCtD
Cabazitaxel—Hypertension—Etoposide—sarcoma	0.000155	0.00124	CcSEcCtD
Cabazitaxel—Pain—Vincristine—sarcoma	0.000154	0.00124	CcSEcCtD
Cabazitaxel—Constipation—Vincristine—sarcoma	0.000154	0.00124	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000154	0.00124	CcSEcCtD
Cabazitaxel—Pain in extremity—Doxorubicin—sarcoma	0.000154	0.00124	CcSEcCtD
Cabazitaxel—Dry skin—Epirubicin—sarcoma	0.000153	0.00123	CcSEcCtD
Cabazitaxel—Decreased appetite—Mitoxantrone—sarcoma	0.000153	0.00123	CcSEcCtD
Cabazitaxel—Chest pain—Etoposide—sarcoma	0.000153	0.00123	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Epirubicin—sarcoma	0.000152	0.00123	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Epirubicin—sarcoma	0.000152	0.00123	CcSEcCtD
Cabazitaxel—Hypokalaemia—Epirubicin—sarcoma	0.000152	0.00122	CcSEcCtD
Cabazitaxel—Fatigue—Mitoxantrone—sarcoma	0.000152	0.00122	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000152	0.00122	CcSEcCtD
Cabazitaxel—Discomfort—Etoposide—sarcoma	0.000151	0.00121	CcSEcCtD
Cabazitaxel—Breast disorder—Epirubicin—sarcoma	0.000151	0.00121	CcSEcCtD
Cabazitaxel—Pain—Mitoxantrone—sarcoma	0.00015	0.00121	CcSEcCtD
Cabazitaxel—Constipation—Mitoxantrone—sarcoma	0.00015	0.00121	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00015	0.00121	CcSEcCtD
Cabazitaxel—Hypersensitivity—Thiotepa—sarcoma	0.00015	0.00121	CcSEcCtD
Cabazitaxel—Hypersensitivity—Dactinomycin—sarcoma	0.000149	0.0012	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Vincristine—sarcoma	0.000148	0.00119	CcSEcCtD
Cabazitaxel—Gastritis—Epirubicin—sarcoma	0.000148	0.00119	CcSEcCtD
Cabazitaxel—Confusional state—Etoposide—sarcoma	0.000148	0.00119	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000147	0.00118	CcSEcCtD
Cabazitaxel—Cardiac arrest—Doxorubicin—sarcoma	0.000147	0.00118	CcSEcCtD
Cabazitaxel—TUBB8—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	0.000146	0.0167	CbGpPWpGaD
Cabazitaxel—Asthenia—Thiotepa—sarcoma	0.000146	0.00118	CcSEcCtD
Cabazitaxel—Infection—Etoposide—sarcoma	0.000145	0.00117	CcSEcCtD
Cabazitaxel—Abdominal distension—Epirubicin—sarcoma	0.000145	0.00117	CcSEcCtD
Cabazitaxel—Asthenia—Dactinomycin—sarcoma	0.000145	0.00117	CcSEcCtD
Cabazitaxel—Feeling abnormal—Mitoxantrone—sarcoma	0.000145	0.00117	CcSEcCtD
Cabazitaxel—Influenza—Epirubicin—sarcoma	0.000144	0.00116	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000144	0.00116	CcSEcCtD
Cabazitaxel—Dehydration—Doxorubicin—sarcoma	0.000144	0.00115	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Etoposide—sarcoma	0.000143	0.00115	CcSEcCtD
Cabazitaxel—Tachycardia—Etoposide—sarcoma	0.000143	0.00115	CcSEcCtD
Cabazitaxel—Abdominal pain—Vincristine—sarcoma	0.000143	0.00115	CcSEcCtD
Cabazitaxel—Body temperature increased—Vincristine—sarcoma	0.000143	0.00115	CcSEcCtD
Cabazitaxel—Skin disorder—Etoposide—sarcoma	0.000142	0.00114	CcSEcCtD
Cabazitaxel—Dry skin—Doxorubicin—sarcoma	0.000142	0.00114	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Doxorubicin—sarcoma	0.000141	0.00113	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Doxorubicin—sarcoma	0.000141	0.00113	CcSEcCtD
Cabazitaxel—Hypokalaemia—Doxorubicin—sarcoma	0.00014	0.00113	CcSEcCtD
Cabazitaxel—Breast disorder—Doxorubicin—sarcoma	0.00014	0.00112	CcSEcCtD
Cabazitaxel—Anorexia—Etoposide—sarcoma	0.000139	0.00112	CcSEcCtD
Cabazitaxel—Diarrhoea—Thiotepa—sarcoma	0.000139	0.00112	CcSEcCtD
Cabazitaxel—Abdominal pain—Mitoxantrone—sarcoma	0.000139	0.00112	CcSEcCtD
Cabazitaxel—Body temperature increased—Mitoxantrone—sarcoma	0.000139	0.00112	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000139	0.00112	CcSEcCtD
Cabazitaxel—Diarrhoea—Dactinomycin—sarcoma	0.000138	0.00111	CcSEcCtD
Cabazitaxel—Hypotension—Etoposide—sarcoma	0.000137	0.0011	CcSEcCtD
Cabazitaxel—Gastritis—Doxorubicin—sarcoma	0.000137	0.0011	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000136	0.0011	CcSEcCtD
Cabazitaxel—Dysuria—Epirubicin—sarcoma	0.000135	0.00108	CcSEcCtD
Cabazitaxel—Neutropenia—Epirubicin—sarcoma	0.000135	0.00108	CcSEcCtD
Cabazitaxel—Dizziness—Thiotepa—sarcoma	0.000135	0.00108	CcSEcCtD
Cabazitaxel—Abdominal distension—Doxorubicin—sarcoma	0.000134	0.00108	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Epirubicin—sarcoma	0.000134	0.00108	CcSEcCtD
Cabazitaxel—Influenza—Doxorubicin—sarcoma	0.000133	0.00107	CcSEcCtD
Cabazitaxel—Pollakiuria—Epirubicin—sarcoma	0.000133	0.00107	CcSEcCtD
Cabazitaxel—Hypersensitivity—Vincristine—sarcoma	0.000133	0.00107	CcSEcCtD
Cabazitaxel—Paraesthesia—Etoposide—sarcoma	0.000131	0.00106	CcSEcCtD
Cabazitaxel—Weight decreased—Epirubicin—sarcoma	0.00013	0.00105	CcSEcCtD
Cabazitaxel—Dyspnoea—Etoposide—sarcoma	0.00013	0.00105	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Epirubicin—sarcoma	0.00013	0.00105	CcSEcCtD
Cabazitaxel—Hypersensitivity—Mitoxantrone—sarcoma	0.00013	0.00104	CcSEcCtD
Cabazitaxel—Asthenia—Vincristine—sarcoma	0.00013	0.00104	CcSEcCtD
Cabazitaxel—Vomiting—Thiotepa—sarcoma	0.000129	0.00104	CcSEcCtD
Cabazitaxel—Pneumonia—Epirubicin—sarcoma	0.000129	0.00104	CcSEcCtD
Cabazitaxel—Infestation NOS—Epirubicin—sarcoma	0.000129	0.00103	CcSEcCtD
Cabazitaxel—Infestation—Epirubicin—sarcoma	0.000129	0.00103	CcSEcCtD
Cabazitaxel—Vomiting—Dactinomycin—sarcoma	0.000129	0.00103	CcSEcCtD
Cabazitaxel—ABCG2—lymph node—sarcoma	0.000128	0.00212	CbGeAlD
Cabazitaxel—Headache—Thiotepa—sarcoma	0.000128	0.00103	CcSEcCtD
Cabazitaxel—Decreased appetite—Etoposide—sarcoma	0.000127	0.00102	CcSEcCtD
Cabazitaxel—ABCG2—HIF-2-alpha transcription factor network—FLT1—sarcoma	0.000127	0.0145	CbGpPWpGaD
Cabazitaxel—Renal failure—Epirubicin—sarcoma	0.000126	0.00102	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Etoposide—sarcoma	0.000126	0.00102	CcSEcCtD
Cabazitaxel—Asthenia—Mitoxantrone—sarcoma	0.000126	0.00101	CcSEcCtD
Cabazitaxel—Fatigue—Etoposide—sarcoma	0.000126	0.00101	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Epirubicin—sarcoma	0.000126	0.00101	CcSEcCtD
Cabazitaxel—Pain—Etoposide—sarcoma	0.000125	0.00101	CcSEcCtD
Cabazitaxel—Constipation—Etoposide—sarcoma	0.000125	0.00101	CcSEcCtD
Cabazitaxel—Conjunctivitis—Epirubicin—sarcoma	0.000125	0.00101	CcSEcCtD
Cabazitaxel—Urinary tract infection—Epirubicin—sarcoma	0.000125	0.00101	CcSEcCtD
Cabazitaxel—Dysuria—Doxorubicin—sarcoma	0.000125	0.001	CcSEcCtD
Cabazitaxel—Neutropenia—Doxorubicin—sarcoma	0.000125	0.001	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000124	0.000997	CcSEcCtD
Cabazitaxel—Diarrhoea—Vincristine—sarcoma	0.000124	0.000994	CcSEcCtD
Cabazitaxel—Pollakiuria—Doxorubicin—sarcoma	0.000123	0.000991	CcSEcCtD
Cabazitaxel—Haematuria—Epirubicin—sarcoma	0.000123	0.000986	CcSEcCtD
Cabazitaxel—Nausea—Thiotepa—sarcoma	0.000121	0.000973	CcSEcCtD
Cabazitaxel—Weight decreased—Doxorubicin—sarcoma	0.000121	0.000971	CcSEcCtD
Cabazitaxel—Feeling abnormal—Etoposide—sarcoma	0.000121	0.00097	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Doxorubicin—sarcoma	0.00012	0.000968	CcSEcCtD
Cabazitaxel—Diarrhoea—Mitoxantrone—sarcoma	0.00012	0.000968	CcSEcCtD
Cabazitaxel—Nausea—Dactinomycin—sarcoma	0.00012	0.000966	CcSEcCtD
Cabazitaxel—ABCB1—uterus—sarcoma	0.00012	0.00199	CbGeAlD
Cabazitaxel—Pneumonia—Doxorubicin—sarcoma	0.00012	0.000962	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Etoposide—sarcoma	0.00012	0.000962	CcSEcCtD
Cabazitaxel—Dizziness—Vincristine—sarcoma	0.000119	0.000961	CcSEcCtD
Cabazitaxel—Infestation NOS—Doxorubicin—sarcoma	0.000119	0.000957	CcSEcCtD
Cabazitaxel—Infestation—Doxorubicin—sarcoma	0.000119	0.000957	CcSEcCtD
Cabazitaxel—ABCG2—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000118	0.0135	CbGpPWpGaD
Cabazitaxel—Renal failure—Doxorubicin—sarcoma	0.000117	0.000941	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Doxorubicin—sarcoma	0.000117	0.000938	CcSEcCtD
Cabazitaxel—CYP3A4—liver—sarcoma	0.000116	0.00193	CbGeAlD
Cabazitaxel—Body temperature increased—Etoposide—sarcoma	0.000116	0.00093	CcSEcCtD
Cabazitaxel—Abdominal pain—Etoposide—sarcoma	0.000116	0.00093	CcSEcCtD
Cabazitaxel—Conjunctivitis—Doxorubicin—sarcoma	0.000116	0.00093	CcSEcCtD
Cabazitaxel—Urinary tract infection—Doxorubicin—sarcoma	0.000116	0.00093	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Epirubicin—sarcoma	0.000115	0.000924	CcSEcCtD
Cabazitaxel—Vomiting—Vincristine—sarcoma	0.000115	0.000924	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Epirubicin—sarcoma	0.000114	0.000917	CcSEcCtD
Cabazitaxel—Oedema peripheral—Epirubicin—sarcoma	0.000114	0.000915	CcSEcCtD
Cabazitaxel—Haematuria—Doxorubicin—sarcoma	0.000113	0.000912	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Epirubicin—sarcoma	0.000113	0.000912	CcSEcCtD
Cabazitaxel—Urethral disorder—Epirubicin—sarcoma	0.000113	0.00091	CcSEcCtD
Cabazitaxel—Headache—Vincristine—sarcoma	0.000113	0.00091	CcSEcCtD
Cabazitaxel—ABCB1—lymphoid tissue—sarcoma	0.000112	0.00185	CbGeAlD
Cabazitaxel—Vomiting—Mitoxantrone—sarcoma	0.000112	0.000899	CcSEcCtD
Cabazitaxel—Headache—Mitoxantrone—sarcoma	0.00011	0.000886	CcSEcCtD
Cabazitaxel—Eye disorder—Epirubicin—sarcoma	0.000108	0.000868	CcSEcCtD
Cabazitaxel—Hypersensitivity—Etoposide—sarcoma	0.000108	0.000867	CcSEcCtD
Cabazitaxel—Tinnitus—Epirubicin—sarcoma	0.000108	0.000866	CcSEcCtD
Cabazitaxel—Nausea—Vincristine—sarcoma	0.000107	0.000863	CcSEcCtD
Cabazitaxel—Cardiac disorder—Epirubicin—sarcoma	0.000107	0.000862	CcSEcCtD
Cabazitaxel—Flushing—Epirubicin—sarcoma	0.000107	0.000862	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Doxorubicin—sarcoma	0.000106	0.000855	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Doxorubicin—sarcoma	0.000105	0.000848	CcSEcCtD
Cabazitaxel—Oedema peripheral—Doxorubicin—sarcoma	0.000105	0.000846	CcSEcCtD
Cabazitaxel—Asthenia—Etoposide—sarcoma	0.000105	0.000844	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Doxorubicin—sarcoma	0.000105	0.000844	CcSEcCtD
Cabazitaxel—Angiopathy—Epirubicin—sarcoma	0.000105	0.000842	CcSEcCtD
Cabazitaxel—Urethral disorder—Doxorubicin—sarcoma	0.000105	0.000842	CcSEcCtD
Cabazitaxel—Nausea—Mitoxantrone—sarcoma	0.000104	0.00084	CcSEcCtD
Cabazitaxel—Immune system disorder—Epirubicin—sarcoma	0.000104	0.000839	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Epirubicin—sarcoma	0.000104	0.000837	CcSEcCtD
Cabazitaxel—Chills—Epirubicin—sarcoma	0.000104	0.000833	CcSEcCtD
Cabazitaxel—Arrhythmia—Epirubicin—sarcoma	0.000103	0.000829	CcSEcCtD
Cabazitaxel—Alopecia—Epirubicin—sarcoma	0.000102	0.00082	CcSEcCtD
Cabazitaxel—ABCB1—bone marrow—sarcoma	0.000102	0.00169	CbGeAlD
Cabazitaxel—Mental disorder—Epirubicin—sarcoma	0.000101	0.000813	CcSEcCtD
Cabazitaxel—Erythema—Epirubicin—sarcoma	0.0001	0.000808	CcSEcCtD
Cabazitaxel—Malnutrition—Epirubicin—sarcoma	0.0001	0.000808	CcSEcCtD
Cabazitaxel—Diarrhoea—Etoposide—sarcoma	0.0001	0.000805	CcSEcCtD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—NPM1—sarcoma	9.99e-05	0.0114	CbGpPWpGaD
Cabazitaxel—Eye disorder—Doxorubicin—sarcoma	9.98e-05	0.000803	CcSEcCtD
Cabazitaxel—Tinnitus—Doxorubicin—sarcoma	9.96e-05	0.000801	CcSEcCtD
Cabazitaxel—Flushing—Doxorubicin—sarcoma	9.91e-05	0.000797	CcSEcCtD
Cabazitaxel—Cardiac disorder—Doxorubicin—sarcoma	9.91e-05	0.000797	CcSEcCtD
Cabazitaxel—Dysgeusia—Epirubicin—sarcoma	9.84e-05	0.000791	CcSEcCtD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—VEGFC—sarcoma	9.81e-05	0.0112	CbGpPWpGaD
Cabazitaxel—Back pain—Epirubicin—sarcoma	9.72e-05	0.000782	CcSEcCtD
Cabazitaxel—Angiopathy—Doxorubicin—sarcoma	9.69e-05	0.000779	CcSEcCtD
Cabazitaxel—Dizziness—Etoposide—sarcoma	9.67e-05	0.000778	CcSEcCtD
Cabazitaxel—Muscle spasms—Epirubicin—sarcoma	9.66e-05	0.000777	CcSEcCtD
Cabazitaxel—Immune system disorder—Doxorubicin—sarcoma	9.65e-05	0.000776	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Doxorubicin—sarcoma	9.63e-05	0.000774	CcSEcCtD
Cabazitaxel—Chills—Doxorubicin—sarcoma	9.58e-05	0.000771	CcSEcCtD
Cabazitaxel—Arrhythmia—Doxorubicin—sarcoma	9.54e-05	0.000767	CcSEcCtD
Cabazitaxel—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	9.48e-05	0.0109	CbGpPWpGaD
Cabazitaxel—Alopecia—Doxorubicin—sarcoma	9.44e-05	0.000759	CcSEcCtD
Cabazitaxel—Mental disorder—Doxorubicin—sarcoma	9.36e-05	0.000753	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Epirubicin—sarcoma	9.32e-05	0.00075	CcSEcCtD
Cabazitaxel—Vomiting—Etoposide—sarcoma	9.3e-05	0.000748	CcSEcCtD
Cabazitaxel—Erythema—Doxorubicin—sarcoma	9.3e-05	0.000748	CcSEcCtD
Cabazitaxel—Malnutrition—Doxorubicin—sarcoma	9.3e-05	0.000748	CcSEcCtD
Cabazitaxel—Anaemia—Epirubicin—sarcoma	9.29e-05	0.000747	CcSEcCtD
Cabazitaxel—Headache—Etoposide—sarcoma	9.16e-05	0.000737	CcSEcCtD
Cabazitaxel—Dysgeusia—Doxorubicin—sarcoma	9.1e-05	0.000732	CcSEcCtD
Cabazitaxel—Malaise—Epirubicin—sarcoma	9.06e-05	0.000729	CcSEcCtD
Cabazitaxel—Vertigo—Epirubicin—sarcoma	9.03e-05	0.000726	CcSEcCtD
Cabazitaxel—Leukopenia—Epirubicin—sarcoma	8.99e-05	0.000723	CcSEcCtD
Cabazitaxel—Back pain—Doxorubicin—sarcoma	8.99e-05	0.000723	CcSEcCtD
Cabazitaxel—Muscle spasms—Doxorubicin—sarcoma	8.94e-05	0.000719	CcSEcCtD
Cabazitaxel—Cough—Epirubicin—sarcoma	8.77e-05	0.000705	CcSEcCtD
Cabazitaxel—ABCB1—testis—sarcoma	8.71e-05	0.00144	CbGeAlD
Cabazitaxel—Nausea—Etoposide—sarcoma	8.69e-05	0.000699	CcSEcCtD
Cabazitaxel—Hypertension—Epirubicin—sarcoma	8.67e-05	0.000698	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Doxorubicin—sarcoma	8.63e-05	0.000694	CcSEcCtD
Cabazitaxel—TUBA4A—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	8.61e-05	0.00987	CbGpPWpGaD
Cabazitaxel—Anaemia—Doxorubicin—sarcoma	8.59e-05	0.000691	CcSEcCtD
Cabazitaxel—Myalgia—Epirubicin—sarcoma	8.55e-05	0.000688	CcSEcCtD
Cabazitaxel—Chest pain—Epirubicin—sarcoma	8.55e-05	0.000688	CcSEcCtD
Cabazitaxel—Arthralgia—Epirubicin—sarcoma	8.55e-05	0.000688	CcSEcCtD
Cabazitaxel—Anxiety—Epirubicin—sarcoma	8.52e-05	0.000686	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	8.5e-05	0.000683	CcSEcCtD
Cabazitaxel—Discomfort—Epirubicin—sarcoma	8.45e-05	0.00068	CcSEcCtD
Cabazitaxel—Malaise—Doxorubicin—sarcoma	8.38e-05	0.000674	CcSEcCtD
Cabazitaxel—Dry mouth—Epirubicin—sarcoma	8.37e-05	0.000673	CcSEcCtD
Cabazitaxel—Vertigo—Doxorubicin—sarcoma	8.35e-05	0.000672	CcSEcCtD
Cabazitaxel—Leukopenia—Doxorubicin—sarcoma	8.32e-05	0.000669	CcSEcCtD
Cabazitaxel—Confusional state—Epirubicin—sarcoma	8.27e-05	0.000665	CcSEcCtD
Cabazitaxel—ABCB1—liver—sarcoma	8.23e-05	0.00136	CbGeAlD
Cabazitaxel—Oedema—Epirubicin—sarcoma	8.2e-05	0.00066	CcSEcCtD
Cabazitaxel—Infection—Epirubicin—sarcoma	8.15e-05	0.000655	CcSEcCtD
Cabazitaxel—Cough—Doxorubicin—sarcoma	8.11e-05	0.000653	CcSEcCtD
Cabazitaxel—Nervous system disorder—Epirubicin—sarcoma	8.04e-05	0.000647	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Epirubicin—sarcoma	8.03e-05	0.000646	CcSEcCtD
Cabazitaxel—Hypertension—Doxorubicin—sarcoma	8.03e-05	0.000646	CcSEcCtD
Cabazitaxel—Tachycardia—Epirubicin—sarcoma	8e-05	0.000644	CcSEcCtD
Cabazitaxel—Skin disorder—Epirubicin—sarcoma	7.97e-05	0.000641	CcSEcCtD
Cabazitaxel—Myalgia—Doxorubicin—sarcoma	7.92e-05	0.000637	CcSEcCtD
Cabazitaxel—Arthralgia—Doxorubicin—sarcoma	7.92e-05	0.000637	CcSEcCtD
Cabazitaxel—Chest pain—Doxorubicin—sarcoma	7.92e-05	0.000637	CcSEcCtD
Cabazitaxel—Anxiety—Doxorubicin—sarcoma	7.89e-05	0.000634	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	7.86e-05	0.000632	CcSEcCtD
Cabazitaxel—Discomfort—Doxorubicin—sarcoma	7.82e-05	0.000629	CcSEcCtD
Cabazitaxel—Anorexia—Epirubicin—sarcoma	7.82e-05	0.000629	CcSEcCtD
Cabazitaxel—Dry mouth—Doxorubicin—sarcoma	7.74e-05	0.000623	CcSEcCtD
Cabazitaxel—Hypotension—Epirubicin—sarcoma	7.66e-05	0.000616	CcSEcCtD
Cabazitaxel—Confusional state—Doxorubicin—sarcoma	7.65e-05	0.000615	CcSEcCtD
Cabazitaxel—Oedema—Doxorubicin—sarcoma	7.59e-05	0.00061	CcSEcCtD
Cabazitaxel—Infection—Doxorubicin—sarcoma	7.54e-05	0.000606	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Epirubicin—sarcoma	7.47e-05	0.000601	CcSEcCtD
Cabazitaxel—Nervous system disorder—Doxorubicin—sarcoma	7.44e-05	0.000598	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Doxorubicin—sarcoma	7.43e-05	0.000598	CcSEcCtD
Cabazitaxel—Tachycardia—Doxorubicin—sarcoma	7.41e-05	0.000596	CcSEcCtD
Cabazitaxel—TUBB6—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	7.39e-05	0.00847	CbGpPWpGaD
Cabazitaxel—TUBB2B—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	7.39e-05	0.00847	CbGpPWpGaD
Cabazitaxel—Skin disorder—Doxorubicin—sarcoma	7.37e-05	0.000593	CcSEcCtD
Cabazitaxel—Paraesthesia—Epirubicin—sarcoma	7.36e-05	0.000592	CcSEcCtD
Cabazitaxel—ABCG2—HIF-2-alpha transcription factor network—KDR—sarcoma	7.32e-05	0.00839	CbGpPWpGaD
Cabazitaxel—TUBB—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	7.32e-05	0.00839	CbGpPWpGaD
Cabazitaxel—Dyspnoea—Epirubicin—sarcoma	7.31e-05	0.000588	CcSEcCtD
Cabazitaxel—Anorexia—Doxorubicin—sarcoma	7.23e-05	0.000582	CcSEcCtD
Cabazitaxel—Dyspepsia—Epirubicin—sarcoma	7.22e-05	0.000581	CcSEcCtD
Cabazitaxel—TUBB3—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	7.14e-05	0.00818	CbGpPWpGaD
Cabazitaxel—Decreased appetite—Epirubicin—sarcoma	7.13e-05	0.000573	CcSEcCtD
Cabazitaxel—Hypotension—Doxorubicin—sarcoma	7.09e-05	0.00057	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Epirubicin—sarcoma	7.08e-05	0.000569	CcSEcCtD
Cabazitaxel—Fatigue—Epirubicin—sarcoma	7.07e-05	0.000569	CcSEcCtD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—CXCR4—sarcoma	7.05e-05	0.00808	CbGpPWpGaD
Cabazitaxel—Pain—Epirubicin—sarcoma	7.01e-05	0.000564	CcSEcCtD
Cabazitaxel—Constipation—Epirubicin—sarcoma	7.01e-05	0.000564	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Doxorubicin—sarcoma	6.91e-05	0.000556	CcSEcCtD
Cabazitaxel—TUBB2A—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	6.91e-05	0.00792	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TEK—sarcoma	6.89e-05	0.00789	CbGpPWpGaD
Cabazitaxel—Paraesthesia—Doxorubicin—sarcoma	6.81e-05	0.000548	CcSEcCtD
Cabazitaxel—Dyspnoea—Doxorubicin—sarcoma	6.76e-05	0.000544	CcSEcCtD
Cabazitaxel—TUBB1—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	6.76e-05	0.00774	CbGpPWpGaD
Cabazitaxel—Feeling abnormal—Epirubicin—sarcoma	6.76e-05	0.000544	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Epirubicin—sarcoma	6.71e-05	0.000539	CcSEcCtD
Cabazitaxel—Dyspepsia—Doxorubicin—sarcoma	6.68e-05	0.000537	CcSEcCtD
Cabazitaxel—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	6.66e-05	0.00763	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—STAG1—sarcoma	6.65e-05	0.00762	CbGpPWpGaD
Cabazitaxel—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	6.6e-05	0.00756	CbGpPWpGaD
Cabazitaxel—Decreased appetite—Doxorubicin—sarcoma	6.6e-05	0.000531	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Doxorubicin—sarcoma	6.55e-05	0.000527	CcSEcCtD
Cabazitaxel—Fatigue—Doxorubicin—sarcoma	6.54e-05	0.000526	CcSEcCtD
Cabazitaxel—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	6.49e-05	0.00744	CbGpPWpGaD
Cabazitaxel—Constipation—Doxorubicin—sarcoma	6.49e-05	0.000522	CcSEcCtD
Cabazitaxel—Pain—Doxorubicin—sarcoma	6.49e-05	0.000522	CcSEcCtD
Cabazitaxel—Body temperature increased—Epirubicin—sarcoma	6.48e-05	0.000521	CcSEcCtD
Cabazitaxel—Abdominal pain—Epirubicin—sarcoma	6.48e-05	0.000521	CcSEcCtD
Cabazitaxel—ABCB1—lymph node—sarcoma	6.31e-05	0.00105	CbGeAlD
Cabazitaxel—TUBA4A—Hemostasis—ANGPT2—sarcoma	6.3e-05	0.00722	CbGpPWpGaD
Cabazitaxel—Feeling abnormal—Doxorubicin—sarcoma	6.25e-05	0.000503	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Doxorubicin—sarcoma	6.2e-05	0.000499	CcSEcCtD
Cabazitaxel—TUBB4A—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	6.07e-05	0.00695	CbGpPWpGaD
Cabazitaxel—TUBB2A—Signaling events mediated by HDAC Class III—TP53—sarcoma	6.05e-05	0.00694	CbGpPWpGaD
Cabazitaxel—Hypersensitivity—Epirubicin—sarcoma	6.04e-05	0.000486	CcSEcCtD
Cabazitaxel—Abdominal pain—Doxorubicin—sarcoma	6e-05	0.000482	CcSEcCtD
Cabazitaxel—Body temperature increased—Doxorubicin—sarcoma	6e-05	0.000482	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle—STAG1—sarcoma	5.94e-05	0.00681	CbGpPWpGaD
Cabazitaxel—Asthenia—Epirubicin—sarcoma	5.88e-05	0.000473	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—STAG1—sarcoma	5.65e-05	0.00648	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet degranulation—VEGFA—sarcoma	5.62e-05	0.00644	CbGpPWpGaD
Cabazitaxel—Diarrhoea—Epirubicin—sarcoma	5.61e-05	0.000451	CcSEcCtD
Cabazitaxel—Hypersensitivity—Doxorubicin—sarcoma	5.59e-05	0.00045	CcSEcCtD
Cabazitaxel—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	5.55e-05	0.00636	CbGpPWpGaD
Cabazitaxel—Asthenia—Doxorubicin—sarcoma	5.44e-05	0.000438	CcSEcCtD
Cabazitaxel—Dizziness—Epirubicin—sarcoma	5.42e-05	0.000436	CcSEcCtD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	5.4e-05	0.00619	CbGpPWpGaD
Cabazitaxel—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	5.35e-05	0.00613	CbGpPWpGaD
Cabazitaxel—Vomiting—Epirubicin—sarcoma	5.21e-05	0.000419	CcSEcCtD
Cabazitaxel—Diarrhoea—Doxorubicin—sarcoma	5.19e-05	0.000418	CcSEcCtD
Cabazitaxel—Headache—Epirubicin—sarcoma	5.14e-05	0.000413	CcSEcCtD
Cabazitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	5.12e-05	0.00587	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—NPM1—sarcoma	5.1e-05	0.00584	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—VEGFC—sarcoma	5.06e-05	0.00579	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—STAG1—sarcoma	5.05e-05	0.00579	CbGpPWpGaD
Cabazitaxel—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	5.04e-05	0.00577	CbGpPWpGaD
Cabazitaxel—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	5.02e-05	0.00576	CbGpPWpGaD
Cabazitaxel—Dizziness—Doxorubicin—sarcoma	5.02e-05	0.000404	CcSEcCtD
Cabazitaxel—Nausea—Epirubicin—sarcoma	4.87e-05	0.000392	CcSEcCtD
Cabazitaxel—Vomiting—Doxorubicin—sarcoma	4.82e-05	0.000388	CcSEcCtD
Cabazitaxel—Headache—Doxorubicin—sarcoma	4.75e-05	0.000382	CcSEcCtD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—STAG1—sarcoma	4.68e-05	0.00537	CbGpPWpGaD
Cabazitaxel—Nausea—Doxorubicin—sarcoma	4.51e-05	0.000362	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle—NPM1—sarcoma	4.34e-05	0.00497	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—STAG1—sarcoma	4.28e-05	0.00491	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—STAG1—sarcoma	4.19e-05	0.0048	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-2-alpha transcription factor network—VEGFA—sarcoma	4.03e-05	0.00462	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—PLCG1—sarcoma	3.97e-05	0.00455	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—STAG1—sarcoma	3.83e-05	0.00439	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	3.81e-05	0.00437	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—CREB1—sarcoma	3.78e-05	0.00433	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—NPM1—sarcoma	3.59e-05	0.00412	CbGpPWpGaD
Cabazitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	3.57e-05	0.00409	CbGpPWpGaD
Cabazitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	3.51e-05	0.00402	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—NPM1—sarcoma	3.29e-05	0.00377	CbGpPWpGaD
Cabazitaxel—ABCG2—Fluoropyrimidine Activity—TP53—sarcoma	3.12e-05	0.00358	CbGpPWpGaD
Cabazitaxel—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	3.1e-05	0.00355	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—IL2—sarcoma	2.93e-05	0.00336	CbGpPWpGaD
Cabazitaxel—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	2.77e-05	0.00318	CbGpPWpGaD
Cabazitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	2.72e-05	0.00312	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—JUN—sarcoma	2.72e-05	0.00311	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—SRC—sarcoma	2.56e-05	0.00293	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—sarcoma	2.49e-05	0.00286	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—PDGFRA—sarcoma	2.4e-05	0.00275	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	2.37e-05	0.00272	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	2.23e-05	0.00255	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	2.04e-05	0.00234	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—MDM2—sarcoma	1.6e-05	0.00183	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—CCND1—sarcoma	1.56e-05	0.00178	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—IL2—sarcoma	1.51e-05	0.00173	CbGpPWpGaD
Cabazitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	1.5e-05	0.00172	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—MMP2—sarcoma	1.5e-05	0.00172	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	1.47e-05	0.00168	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—CCND1—sarcoma	1.39e-05	0.00159	CbGpPWpGaD
Cabazitaxel—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	1.39e-05	0.00159	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—MDM2—sarcoma	1.36e-05	0.00156	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—CCND1—sarcoma	1.32e-05	0.00152	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—SRC—sarcoma	1.32e-05	0.00151	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL2—sarcoma	1.31e-05	0.0015	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—MMP2—sarcoma	1.28e-05	0.00147	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—MMP2—sarcoma	1.28e-05	0.00147	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—VEGFA—sarcoma	1.28e-05	0.00147	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	1.28e-05	0.00147	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—NRAS—sarcoma	1.27e-05	0.00145	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—MYC—sarcoma	1.25e-05	0.00143	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—MMP2—sarcoma	1.24e-05	0.00142	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—MMP2—sarcoma	1.2e-05	0.00138	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	1.18e-05	0.00136	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CCND1—sarcoma	1.18e-05	0.00135	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—MMP2—sarcoma	1.17e-05	0.00135	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—CTNNB1—sarcoma	1.15e-05	0.00132	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MDM2—sarcoma	1.12e-05	0.00129	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—MYC—sarcoma	1.12e-05	0.00128	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—VEGFA—sarcoma	1.11e-05	0.00127	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ENO2—sarcoma	1.11e-05	0.00127	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—HBA1—sarcoma	1.1e-05	0.00126	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CCND1—sarcoma	1.1e-05	0.00126	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—KRAS—sarcoma	1.09e-05	0.00125	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—MYC—sarcoma	1.06e-05	0.00122	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—MMP2—sarcoma	1.05e-05	0.00121	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MDM2—sarcoma	1.03e-05	0.00118	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—sarcoma	1e-05	0.00115	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—CTNNB1—sarcoma	9.85e-06	0.00113	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—CTNNB1—sarcoma	9.85e-06	0.00113	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CCND1—sarcoma	9.8e-06	0.00112	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TP53—sarcoma	9.71e-06	0.00111	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—MMP2—sarcoma	9.65e-06	0.00111	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—CTNNB1—sarcoma	9.51e-06	0.00109	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—MYC—sarcoma	9.48e-06	0.00109	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PLCG1—sarcoma	9.38e-06	0.00107	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—HRAS—sarcoma	9.28e-06	0.00106	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—CTNNB1—sarcoma	9.21e-06	0.00106	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TP53—sarcoma	9.16e-06	0.00105	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—CTNNB1—sarcoma	9.01e-06	0.00103	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CCND1—sarcoma	8.96e-06	0.00103	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—MYC—sarcoma	8.79e-06	0.00101	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	8.73e-06	0.001	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—CTNNB1—sarcoma	8.09e-06	0.000927	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—MYC—sarcoma	8.04e-06	0.000921	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MYC—sarcoma	7.86e-06	0.0009	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—sarcoma	7.79e-06	0.000892	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ENO2—sarcoma	7.43e-06	0.000851	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—CTNNB1—sarcoma	7.4e-06	0.000848	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—HBA1—sarcoma	7.38e-06	0.000846	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	7.22e-06	0.000827	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MYC—sarcoma	7.19e-06	0.000824	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ENO2—sarcoma	6.88e-06	0.000788	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—HBA1—sarcoma	6.83e-06	0.000783	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—sarcoma	6.45e-06	0.000739	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PLCG1—sarcoma	6.3e-06	0.000722	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	6.29e-06	0.000721	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	6.28e-06	0.000719	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	6.23e-06	0.000714	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—sarcoma	5.9e-06	0.000676	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PLCG1—sarcoma	5.83e-06	0.000668	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	5.63e-06	0.000645	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	5.48e-06	0.000628	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	5.05e-06	0.000578	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	4.93e-06	0.000565	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ENO2—sarcoma	4.93e-06	0.000564	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—HBA1—sarcoma	4.9e-06	0.000561	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	4.66e-06	0.000534	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ENO2—sarcoma	4.27e-06	0.000489	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—HBA1—sarcoma	4.24e-06	0.000486	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PLCG1—sarcoma	4.18e-06	0.000479	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	4.14e-06	0.000475	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ENO2—sarcoma	3.72e-06	0.000426	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HBA1—sarcoma	3.69e-06	0.000423	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PLCG1—sarcoma	3.62e-06	0.000415	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PLCG1—sarcoma	3.15e-06	0.000361	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ENO2—sarcoma	2.29e-06	0.000262	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HBA1—sarcoma	2.28e-06	0.000261	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PLCG1—sarcoma	1.94e-06	0.000223	CbGpPWpGaD
